Heparin-induced thrombocytopenia in a patient treated with fondaparinux

Clinical Advances in Hematology and Oncology

Volumn 8, Issue 1, 2010, Pages 61-62

  Ratuapli, Shiva K ^a   Bobba, Brijesh ^a   Zafar, Haider ^a  

^a Banner Estrella Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENOXAPARIN; FONDAPARINUX; HEPARIN; LEPIRUDIN; WARFARIN;

ADULT; ANTICOAGULANT THERAPY; ARTICLE; BILE DUCT CARCINOMA; CASE REPORT; CYANOSIS; DEEP VEIN THROMBOSIS; DRUG INDUCED DISEASE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; FONDAPARINUX INDUCED THROMBOCYTOPENIA; FOOT EDEMA; HEPARIN INDUCED THROMBOCYTOPENIA; HUMAN; HUMAN TISSUE; INTERNATIONAL NORMALIZED RATIO; LEG CRAMP; LUNG EMBOLISM; METASTASIS; PANCREAS ADENOCARCINOMA; THROMBOCYTE COUNT; THROMBOCYTOPENIA;

ANTICOAGULANTS; FEMALE; HEMATOCRIT; HEPARIN; HIRUDINS; HUMANS; MIDDLE AGED; PLATELET COUNT; POLYSACCHARIDES; RECOMBINANT PROTEINS; THROMBOCYTOPENIA; VENOUS THROMBOSIS;

EID: 76149104272     PISSN: 15430790     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Shantsila E, GY Lip, BH Chong. Heparin-induced thrombocytopenia. A contemporary clinical approach to diagnosis and management. Chest. 2009; 135:1651-1664.
2. Tardy-Poncet B, Piot M, Chapelle C, et al. Thrombin generation and heparininduced thrombocytopenia (HIT). J Thromb Haemost. 2009;7:1474-1481.
3. Schneiter S, Colucci G, Sulzer I, Barizzi G, Lämmle B, Alberio L. Variability of anti-PF4/heparin antibody results obtained by the rapid testing system ID-H/ PF4-PaGIA. J Thromb Haemost. 2009;7:1649-1655.
4. Amiral J, Peynaud-Debayle E, Wolf M, Bridey F, Vissac AM, Meyer D. Generation of antibodies to heparin-PF4 complexes without thrombocytopenia in patients treated with unfractionated or low-molecular-weight heparin. Am J Hematol. 1996;52:90-95.
5. Efird LE, Kockler DR. Fondaparinux for thromboembolic treatment and prophylaxis of heparin-induced thrombocytopenia. Ann Pharmacother. 2006;40: 1383-1387.
6. Filis K, Lagoudianakis EE, Pappas A, et al. Heparin-induced thrombocytopenia and phlegmasia cerulea dolens of the upper limb successfully treated with fondaparinux. Acta Haematol. 2008;120:190-191.
7. Lobo B, Finch C, Howard A, Minhas S. Fondaparinux for the treatment of patients with acute heparin-induced thrombocytopenia. Thromb Haemost. 2008;99:208-214.
8. Seldrum S, Lambert M, Hainaut P. Heparin-induced thrombocytopenia successfully treated with fondaparinux. Acta Clin Belg. 2009;64:144-146.
9. Serasli E, Antoniadou M, Tsara V, et al. Successful management of acute thromboembolic disease complicated with heparin induced thrombocytopenia type II (HIT II): a case series. Thromb J. 2008;6:9.
10. Nadar SK, Goyal D, Shantsila E, Banerjee P, Lip GY. Fondaparinux: an overview. Expert Rev Cardiovasc Ther. 2009;7:577-585.
11. Nowicka A, Kandziora M, Szymanowska K, et al. [Heparin-induced thrombocythopenia in a patient with massive pulmonary embolism and dilated cardiomyopathy, successfully treated with fondaparinux - a case report]. Kardiol Pol. 2008;66:1306-1308.
12. Wester JP, Leyte A, Oudemans-van Straaten HM, et al. Low-dose fondaparinux in suspected heparin-induced thrombocytopenia in the critically ill. Neth J Med. 2007;65:101-108.
13. Rota E, Bazzan M, Fantino G. Fondaparinux-related thrombocytopenia in a previous low-molecular-weight heparin (LMWH)-induced heparin-induced thrombocytopenia (HIT). Thromb Haemost. 2008;99:779-781.
14. Warkentin TE, Maurer BT, Aster RH. Heparin-induced thrombocytopenia associated with fondaparinux. N Engl J Med. 2007;356:2653-2655.
15. Baroletti S, Labreche M, Niles M, Fanikos J, Goldhaber SZ. Prescription of fondaparinux in hospitalised patients. Thromb Haemost. 2009;101:1091-1094.